XPA gene polymorphisms and risk of neuroblastoma in Chinese children: a two-center case-control study
This study was conducted to measure the association of XPA polymorphisms with neuroblastoma susceptibility in Chinese children. In this hospital-based case-control study with 393 cases and 812 controls, we genotyped two polymorphisms (rs1800975 T>C, and rs3176752 G>T) in XPA gene to access their contributions to neuroblastoma risk by TaqMan methods. The strength of the association with neuroblastoma risk was estimated by odds ratios (ORs) and 95% confidence intervals (CIs). No single polymorphism was found to predispose to neuroblastoma susceptibility. When risk genotypes were combined, we found that carriers of 1-2 risk genotypes had significantly increased neuroblastoma risk (adjusted OR=1.28; 95% CI=1.001-1.64, P=0.049), when compared to non-carriers. Stratification analysis by age, gender, sites of origin and clinical stages failed to show any significant association. Our study provides cues that XPA gene polymorphisms may exert a weak effect in neuroblastoma risk. This finding needs further validations by larger sample size studies.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Jing Tao, Zhen-Jian Zhuo, Meng Su, Lizhao Yan, Jing He, Jiao Zhang Tags: Research Paper Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Children | China Health | Genetics | Hospitals | Men | Neuroblastoma | Neurology | Reflex Sympathetic Dystrophy | Study